We are live on
!
Find out more
AHS
Aspiriant Holdings S3 Portfolio holdings
AUM
$233M
1-Year Est. Return
3.13%
This Fund
S&P 500
This Quarter
Est. Return
+4.57%
1 Year Est. Return
-3.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$242M
AUM Growth
-$6.93M
(-2.8%)
Cap. Flow
-$17.3M
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
26.42%
Holding
117
New
9
Increased
41
Reduced
53
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$3.87M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$3.1M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$1.97M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$1.29M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$941K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$17M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$3.14M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$2.06M |
| 4 |
Cummins
CMI
|
+$1.98M |
| 5 |
Range Resources
RRC
|
+$1.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.2% |
| 2 | Technology | 11.43% |
| 3 | Healthcare | 10.96% |
| 4 | Industrials | 8.19% |
| 5 | Communication Services | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
AbbVie
ABBV
$431B
| $283K | 0.12% |
4,323
+573
| +15% | +$36.1K |
|
102
Ameriprise Financial
AMP
$48.9B
| $254K | 0.1% |
1,922
| – | – |
|
103
Starbucks
SBUX
$120B
| $252K | 0.1% |
6,142
| – | – |
|
104
IBM
IBM
$222B
| $247K | 0.1% |
1,613
-209
| -11% | -$33.3K |
|
105
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$557M
| $243K | 0.1% |
3,590
-60
| -2% | -$4.37K |
|
106
iShares MSCI Emerging Markets ETF
EEM
$29.7B
| $226K | 0.09% |
5,747
-230
| -4% | -$9.35K |
|
107
Vanguard FTSE All-World ex-US ETF
VEU
$68B
| $208K | 0.09% |
4,441
-15
| -0.3% | -$721 |
|
108
RTX Corp
RTX
$294B
| $203K | 0.08% |
+2,805
| New | +$191K |
|
109
Chubb
CB
$134B
| $202K | 0.08% |
+1,758
| New | +$195K |
|
110
Clorox
CLX
$12.7B
| $202K | 0.08% |
1,936
-515
| -21% | -$51.5K |
|
111
Aflac
AFL
$63.7B
| – | – |
-7,456
| Closed | -$217K |
|
112
iShares MSCI EAFE ETF
EFA
$79.3B
| – | – |
-3,482
| Closed | -$223K |
|
|
113
iShares MSCI Germany ETF
EWG
$1.62B
| – | – |
-113,304
| Closed | -$3.14M |
|
114
Pfizer
PFE
$145B
| – | – |
-9,790
| Closed | -$275K |
|
|
115
Range Resources
RRC
$9.28B
| – | – |
-26,786
| Closed | -$1.82M |
|
116
Valero Energy
VLO
$88.9B
| – | – |
-32,255
| Closed | -$1.49M |
|
Similar funds
SFU
BL
KM
TC
IA
QA
THP
SGH
Aspiriant Holdings S3's Q4 2014 Portfolio in Review
As of Q4 2014, Aspiriant Holdings S3 held 117 positions worth $242M, down 2.8% from $249M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Aspiriant Holdings S3 withdrew a net $17.3M in Q4 2014, closing 6 positions and reducing 53 holdings. Its most notable exit was iShares MSCI Germany ETF, an estimated $3.14M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Aspiriant Holdings S3 opened a new position in VanEck Pharmaceutical ETF worth $3.9M.
- Aspiriant Holdings S3's largest Q4 2014 buy was VanEck Pharmaceutical ETF: 60,765 shares worth $3.9M.
- Aspiriant Holdings S3 added most to Qualcomm in Q4 2014, an estimated $488K increase.
- Aspiriant Holdings S3's biggest Q4 2014 reduction was Schwab US Large- Cap ETF, cutting an estimated $17M.
- Aspiriant Holdings S3 fully exited iShares MSCI Germany ETF in Q4 2014, selling an estimated $3.14M.
- Aspiriant Holdings S3's ten largest holdings make up 26% of its $242M portfolio in Q4 2014.
- Aspiriant Holdings S3 opened 9 new positions and closed 6 in Q4 2014.
- Aspiriant Holdings S3's portfolio value fell 2.8% quarter-over-quarter to $242M.
Based on Aspiriant Holdings S3's 13F filing for Q4 2014, filed 18 Feb 2015.